MedPacto, Inc. (KOSDAQ:235980)
South Korea
· Delayed Price · Currency is KRW 3,290.00
-105.00 (-3.09%)
Apr 24, 2025, 3:30 PM KST
MedPacto Market Cap
MedPacto has a market cap or net worth of 112.77 billion as of April 24, 2025. Its market cap has decreased by -75.67% in one year.
Market Cap
112.77B
Enterprise Value
59.23B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3,290.00
Market Cap Chart
Since December 19, 2019, MedPacto's market cap has decreased from 362.50B to 112.77B, a decrease of -68.89%. That is a compound annual growth rate of -19.61%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.45T |
| Celltrion | 33.91T |
| ALTEOGEN | 20.71T |
| Yuhan | 8,675.28B |
| SK Biopharmaceuticals | 8,168.07B |
| HLB Co., Ltd. | 7,332.20B |
| Peptron | 4,142.27B |
| LigaChem Biosciences | 4,125.27B |